Lilly antibody drug fails in a COVID-19 study; others go on

The National Institute of Allergy and Infectious Diseases said a closer look did not verify a safety problem but found a low chance that the drug would prove helpful for hospitalised patients.

from The Hindu - Science https://ift.tt/31LJHxy

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence